From: Optimization and preparation of in-situ mucoadhesive gel of azithromycin hydroxypropyl-β-cyclodextrin inclusion complex against upper respiratory tract infections
Colony forming units (CFU)/mL
After disease induction
Time
After treatment
Developed formulation
Marketed formulation
13.21 ± 2.48 × 102
24
1.36 ± 0.34 × 102
1.24 ± 0.49 × 102
48
0.64 ± 0.08 × 102
0.93 ± 0.62 × 102